Concourse Financial Group Securities, Inc. Amgen Inc Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

A detailed history of Concourse Financial Group Securities, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 9,647 shares of AMGN stock, worth $2.55 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

9,647

Previous 9,665 0.19%

Holding current value

$2.55 Million

Previous $3.02 Million 2.95%

% of portfolio

0.19%

Previous 0.19%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	SELL	$309.38 - $337.38 $5,568 - $6,072	-18 Reduced 0.19%	9,647 $3.11 Million
Q2 2024 Jul 23, 2024	SELL	$262.75 - $319.31 $28,902 - $35,124	-110 Reduced 1.13%	9,665 $3.02 Million
Q1 2024 Apr 30, 2024	BUY	$268.87 - $324.56 $201,114 - $242,770	748 Added 8.29%	9,775 $2.78 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $443,128 - $499,901	1,733 Added 23.76%	9,027 $2.6 Million
Q3 2023 Oct 25, 2023	BUY	$218.65 - $271.46 $718,483 - $892,017	3,286 Added 81.99%	7,294 $1.96 Million
Q2 2023 Aug 10, 2023	BUY	$214.27 - $253.37 $132,847 - $157,089	620 Added 18.3%	4,008 $889,000
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $84,445 - $102,924	374 Added 12.41%	3,388 $819,000
Q4 2022 Jan 30, 2023	BUY	$229.03 - $291.01 $690,296 - $877,104	3,014 New	3,014 $0
Q3 2022 Nov 15, 2022	SELL	$224.46 - $253.15 $437,921 - $493,895	-1,951 Closed	0 $0
Q2 2022 Aug 09, 2022	SELL	$230.71 - $256.74 $17,303 - $19,255	-75 Reduced 3.7%	1,951 $475,000
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $101,741 - $112,552	-464 Reduced 18.63%	2,026 $490,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $77,165 - $88,308	388 Added 18.46%	2,490 $560,000
Q3 2021 Nov 09, 2021	BUY	$212.27 - $248.7 $61,770 - $72,371	291 Added 16.07%	2,102 $447,000
Q2 2021 Aug 13, 2021	BUY	$233.58 - $259.14 $83,154 - $92,253	356 Added 24.47%	1,811 $441,000
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $94,311 - $109,905	-425 Reduced 22.61%	1,455 $362,000
Q4 2020 Feb 02, 2021	SELL	$216.38 - $257.67 $112,301 - $133,730	-519 Reduced 21.63%	1,880 $432,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $2,815 - $3,131	-12 Reduced 0.5%	2,399 $610,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $30,067 - $36,896	152 Added 6.73%	2,411 $569,000
Q1 2020 May 13, 2020	BUY	$182.24 - $241.7 $411,680 - $546,000	2,259 New	2,259 $458,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $12,013 - $14,394	-69 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $274,888 - $322,231	-1,649 Reduced 95.98%	69 $13,000
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $34,727 - $39,144	-192 Reduced 10.05%	1,718 $326,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $212,831 - $248,442	1,193 Added 166.39%	1,910 $371,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $132,852 - $149,774	717 New	717 $149,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account

Concourse Financial Group Securities, Inc. Amgen Inc Transaction History